A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma

Journal Article Corrected proof A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma Get access Kelly M Hotchkiss, Kelly M Hotchkiss The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Eugene J Cho, Eugene J Cho The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Mustafa Khasraw Mustafa Khasraw The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA Corresponding author: Mustafa Khasraw, MD, The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Box 3624, Durham, NC 27710, USA (mustafa.khasraw@duke.edu). https://orcid.org/0000-0003-3249-9849 Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, noad203, https://doi.org/10.1093/neuonc/noad203 Published: 31 October 2023 Article history Published: 31 October 2023 Corrected and typeset: 09 November 2023